Infinx Services, a healthcare revenue cycle management company backed by KKR, is weighing an initial public offering of as much as $300 million in India, according to people familiar with the matter.
The company would join a healthcare services listing pipeline in India valued at roughly $20 billion this year. Revenue cycle management firms handle billing, claims processing and payment collection for hospitals and medical providers, a function that has drawn institutional capital as India's healthcare sector expands.
Infnix Services processes revenue cycles for hospitals across India. KKR, the buyout firm managing more than $500 billion globally, has backed the company as part of its healthcare infrastructure strategy in Asia. The firm has not announced the IPO publicly, and no timeline has been set.
India's equity markets have absorbed a large wave of healthcare and wellness listings in 2026. Hospital operators, diagnostic chains and telemedicine platforms have filed prospectuses or completed offerings, driven by rising middle-class demand for medical services and government healthcare spending. Infinx would enter a market where similar infrastructure plays have found receptive demand.
Revenue cycle management directly affects hospital cash flow and the speed at which providers recover payment from insurance and patients. Companies in the space typically charge a percentage of revenue collected, creating recurring economics.
KKR has invested in healthcare services across India and Southeast Asia as part of a broader Asia Pacific strategy. The firm has backed hospital networks, diagnostic chains and medical device distributors. An Infinx IPO would be one of the largest fundraising exits from a KKR-backed healthcare services company in India.
Infnix's $300 million target would place it in the middle range of the healthcare listings India has seen this year, above diagnostic chain IPOs but below major hospital network offerings. If completed at that size, the company would be valued by markets at a multiple reflecting both its revenue scale and growth profile in a sector expanding faster than GDP.
The document to watch is Infinx's draft red herring prospectus filing with the Securities and Exchange Board of India, which would confirm the offering size, company financials and timeline.
